Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

TD Cowen upgrades Humana stock rating on earnings outlook

TD Cowen upgrades Humana stock rating on earnings outlook

TD Cowen upgraded Humana's stock rating to "Buy" and raised its price target to $485, citing a positive outlook on earnings growth. The firm anticipates meaningful per-share earnings growth by 2027 and exceeding $40 by 2028, considering 2026 performance, Medicare Advantage benefit design in 2027, and Stars results in 2028. Analysts have raised their earnings estimates for 2026-28 adjusted EPS to $9.51, $18.41, and $40.42, respectively.

Despite a 15.6% decline in the stock price over the past week, Humana has gained 72% over the past year. TD Cowen's analysis highlights positive trends, including recovering Medicare Advantage margins, maturation of 2026 membership, operating leverage, and improved Group MA, Medicaid, and CenterWell earnings. The company's 2028 adjusted EPS estimate of $40.42 surpasses the consensus estimate of $37.81.

Humana's focus on profitability recovery over enrollment for 2027 benefits reduces the risk of competitive disadvantage. The new price target represents 12.0 times the 2028 estimated EPS. Humana reported a better-than-expected adjusted loss per share of $0.70 and revenue of $41.16 billion in Q3 2026, outpacing analyst estimates.

Other analysts also raised their price targets for Humana, indicating strong performance in the third quarter.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in Finance & Markets

More from Friday 20 November →